RT Journal Article
SR Electronic
T1 Homegrown Ultraviolet Germicidal Irradiation for Hospital-Based N95 Decontamination during the COVID-19 Pandemic
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.29.20085456
DO 10.1101/2020.04.29.20085456
A1 Schnell, Eric
A1 Harriff, Melanie J.
A1 Yates, Jane E.
A1 Karamooz, Elham
A1 Pfeiffer, Christopher D.
A1 McCarthy, James F.
A1 Trapp, Christopher L.
A1 Frazier, Sara K.
A1 Dodier, John E.
A1 Smith, Stephen M.
YR 2020
UL http://medrxiv.org/content/early/2020/05/05/2020.04.29.20085456.abstract
AB Coronavirus disease (COVID-19), the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, is responsible for the 2020 global pandemic and characterized by high transmissibility and morbidity. Healthcare workers (HCWs) are at risk of contracting COVID-19, and this risk is mitigated through the use of personal protective equipment such as N95 Filtering Facepiece Respirators (FFRs). The high demand for FFRs is not currently met by global supply chains, potentially placing HCWs at increased exposure risk. Effective FFR decontamination modalities exist, which could maintain respiratory protection for HCWs in the midst of the current pandemic, through the decontamination and re-use of FFRs. Here, we present a locally-implemented ultraviolet-C germicidal irradiation (UVGI)-based FFR decontamination pathway, utilizing a home-built UVGI array assembled entirely with previously existing components available at our institution. We provide recommendations on the construction of similar systems, as well as guidance and strategies towards successful institutional implementation of FFR decontamination.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was explicitly received in support of this work; but the authors would like to acknowledge support by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development Merit Review Awards I01-BX002949 (ES), I01 CX001562 (MH), I01-BX002547 (SMS), a Department of Defense CDMRP Award W81XWH-18-1-0598 (ES), an NIH NINDS 1R21NS102948 (ES), an NIH R01 AI129976 (MH) and an 1R21AI151079-01 (EK).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data will be freely disseminated upon request.